Oct 2026
Prognostic value of CT-measured baseline tumor volume in nivolumab-treated metastatic renal cell carcinoma.
OBJECTIVE To evaluate the association between baseline metastatic tumor volume measured on computed tomography (CT) and survival outcomes in patients with metastatic renal cell carcinoma (mRCC) receiving nivolumab as second line or later line therapy. MATERIALS AND METHODS We retrospectively analyzed 43 patients with...
S. Tacar, D. Tural, M. Nalbant et al.
· Tumori · 0 citations